SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001103021-21-000099
Filing Date
2021-10-21
Accepted
2021-10-21 08:16:05
Documents
3
Period of Report
2021-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kcfotransition102121.htm 8-K 41079
2 EX-99.1 bdsi-cfoappointmentpressre.htm EX-99.1 9881
3 image_0.jpg GRAPHIC 12466
  Complete submission text file 0001103021-21-000099.txt   69630
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31361 | Film No.: 211335782
SIC: 2834 Pharmaceutical Preparations